Search hospitals
>
Michigan
>
Ann Arbor
Saint Joseph Mercy Hospital
Claim this profile
Ann Arbor, Michigan 48105
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
492 reported clinical trials
10 medical researchers
Summary
Saint Joseph Mercy Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. Saint Joseph Mercy Hospital is involved with conducting 492 clinical trials across 552 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Area of expertise
Lung Cancer
Saint Joseph Mercy Hospital has run 76 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Saint Joseph Mercy Hospital has run 62 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Tareq Al Baghdadi
Genesys Hurley Cancer Institute
9 years of reported clinical research
Christopher M. Reynolds, MD
Saint Joseph Mercy Hospital
3 years of reported clinical research
Philip J. Stella
Saint Joseph Mercy Hospital
5 years of reported clinical research
Elie G. Dib
Genesys Hurley Cancer Institute
7 years of reported clinical research
Clinical Trials running at Saint Joseph Mercy Hospital
Bladder Cancer
Lung Cancer
Breast Cancer
Cancer
Ovarian Cancer
Prostate Cancer
Breast cancer
Esophageal cancer
Kidney Cancer
Multiple Myeloma
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting
1 award
Phase 2 & 3
10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Joseph Mercy Hospital?
Saint Joseph Mercy Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. Saint Joseph Mercy Hospital is involved with conducting 492 clinical trials across 552 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint Joseph Mercy Hospital located?
To reach St. Joseph Mercy Hospital in Ann Arbor, Michigan, take I-94 to exit 180B and head north on Washtenaw Avenue. Turn right onto Huron Parkway, then left onto East Huron River Drive. The hospital is located at 5301 East Huron River Drive, Ann Arbor, MI 48106.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Saint Joseph Mercy Hospital, please reach out to the Patient Accounts department at (877) 727-9190. They offer support with medical bills, payment options, financial assistance applications, and insurance benefits. Detailed information on the hospital's financial assistance policy is available on their website.
What insurance does Saint Joseph Mercy Hospital accept?
Saint Joseph Mercy Hospital accepts a variety of health insurance types, including commercial, Medicare, and Medicaid, from many local and national carriers. Before scheduling visits, confirm coverage and restrictions with your insurance provider, as some services may need to be scheduled at specific network locations to avoid denial of coverage. For specific insurance plans accepted and coverage questions, contact your insurance company directly or call the member services number on your insurance card.
What awards or recognition has Saint Joseph Mercy Hospital received?
Saint Joseph Mercy Hospital in Ann Arbor, Michigan, was recognized as the No. 1 teaching hospital in the U.S. by Fortune/IBM Watson Health in 2020. It has been named one of the nation's 100 Top Hospitals by IBM Watson Health ten times, including in 2019. The hospital's health system received a $19.3 million grant in 2019 to lead the Michigan Cancer Research Consortium, one of the largest federal grants Trinity Health has ever received.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.